Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ONO-4578-07 relative bioavailability and food effect in healthy adults
jRCT2071210056Phase 1Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ONO-4578 in Non-hematologic malignancy (3 arms), sponsored by Ono Pharmaceutical. Primary endpoints: Relative bioavailability of ONO-4578 test formulation vs reference formulation and Effect of food on pharmacokinetics of ONO-4578 test formulation. Started Sep 2021; status: completed.
02
Drugs
ONO-4578
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on jRCT2071210056.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071210056.